Panobacumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | Pseudomonas aeruginosa serotype IATS O11 |
| Clinical data | |
| Identifiers | |
885053-97-4  | |
| None | |
| UNII |
62B4OXU259  |
| Chemical data | |
| Formula | C38714H60189N10637O12187S322 |
| 879.9 kDa | |
| (what is this?) (verify) | |
Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against Pseudomonas aeruginosa.[1]
It is a fully human pentameric IgM antibody with a mouse J chain.[1]
Panobacumab molecule consisting of five base units.
1: Base unit.
2: Heavy chains.
3: Light chains.
4: J chain.
5: Intermolecular disulfide bonds.
1: Base unit.
2: Heavy chains.
3: Light chains.
4: J chain.
5: Intermolecular disulfide bonds.
References
- ↑ 1.0 1.1 International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.
| ||||||||||||||||||||||||||||||||||||||||||||||||||